• Explore /
  • Poster
  • / Randomized trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01): A Trans-Tasman Radiation Oncology Group study.

Randomized trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01): A Trans-Tasman Radiation Oncology Group study.

Abstract Video & Slides Poster

Authors

null

Danny Rischin

Department of Medical Oncology, Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

Danny Rischin , Madeleine T. King , Lizbeth M. Kenny , Sandro Porceddu , Christopher Wratten , Andrew Macann , James E Jackson , Mathias Bressel , Alan Herschtal , Fisher Richard , Tsien Fua , Charles Lin , Chen-Shin Liu , Brett Gordon Maxwell Hughes , Margie McGrath , Lachlan McDowell , June Corry

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT01855451

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 6012)

DOI

10.1200/JCO.2021.39.15_suppl.6012

Abstract #

6012

Abstract Disclosures

Similar Posters

First Author: Marshall R. Posner

First Author: Nancy Y. Lee

First Author: Anthony Hee Kong

First Author: Sandro Porceddu